The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms: ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.
- distributive justice
- clinical ethics
This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Vaccine equity in COVID-19: a meta-narrative review
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Ethical allocation of future COVID-19 vaccines
- Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
- An intersectional human rights approach to prioritising access to COVID-19 vaccines
- ‘VaxTax’: a follow-up proposal for a global vaccine pandemic response fund
- WHO’s allocation framework for COVAX: is it fair?
- Love thy neighbour? Allocating vaccines in a world of competing obligations